India faces challenges because of low investment in public health programs, high endemicity in difficult-to-reach locations, and persisting diagnostic gaps.
Published in Indian Journal of Medical Research, study classifies nearly 10% prescriptions as 'unacceptable', says such lapses can lead to adverse drug reactions & risk patient health.
Swiss drugmaker Roche Pharma says Ocrelizumab can help manage multiple sclerosis & impede disability progression. Doctors welcome launch but caution against potential side effects.
The two drugs – Leqembi and Donanemab – are the first to offer real hope of slowing the fatal disease for 6.5 million Americans living with the disease.
At least 70 children died from acute kidney injury in Gambia last year, cases the WHO linked to medicines made by Indian drugmaker Maiden Pharmaceuticals.
Revumenib found to be promising in 2 studies by US researchers published in 'Nature' Wednesday. Leukaemia accounted for nearly 4% of global cancer deaths in 2020.
It is necessary to break the spell of socialist dogma on the imagination of those attracted by its Utopia as the only scientific way of progress, wrote MA Venkatarao in 1963.
While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.
It is one of the most advanced long-range air defence and anti-missile radars. It has been acquired under an about USD 145-million deal signed in 2020.
To be truly functional and durable, even eternal, a state doesn’t just need a leader, a party or an ideology. It needs functional and robust institutions.
COMMENTS